van Loo Anouk, van Loo Eva, Selvadurai Hiran, Cooper Peter, Van Asperen Peter, Fitzgerald Dominic A
Maastricht University, the Netherlands University of Sydney The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
J Paediatr Child Health. 2014 Oct;50(10):823-6. doi: 10.1111/j.1440-1754.2010.01931.x. Epub 2010 Dec 29.
Empyema can be managed conservatively with intravenous antibiotics or invasively with a drain inserted under image guidance or via surgical evacuation. Both approaches are successful but comparisons of the method of drainage are few. This study compared clinical outcomes for empyema in previously well children from a single centre over a 12 year period.
A retrospective analysis of cases over 12 years from the Children's Hospital at Westmead in Sydney was undertaken. Ethics committee approval was obtained.
Seventy two cases were identified from medical records, 12 cases were excluded and 60 cases remained. The mean age was 4.7±4.3 years and there was a slight male preponderance. Treatment was divided into surgical management with a large bore drain alone [n=25] and minimally invasive management with the use of a "pigtail catheter" and intrapleural fibrinolytic ["Urkoinase"][n=35]. At presentation the mean heart rate and respiratory rate were not statistically different. The median (range) number of doses of urokinase was 5.66 doses (1-12). More fluid was drained with the use of urokinase [594 ml (25-4575 ml) vs. 195 ml (10-1426 ml); p=0.006], but this did not influence the rate of resolution of fever or the length of hospital stay. A pathogen was isolated in 42.9% of the urokinase group and 68% of the surgical group which approached statistical significance [p=0.054].
Both large bore surgical drains and "pigtail catheter" drains with the instillation of urokinase lead to similarly favourable treatment outcomes. Either treatment could be recommended depending on local expertise and preferences.
脓胸的治疗可以采用静脉使用抗生素的保守方法,也可以采用在影像引导下插入引流管或通过手术引流的侵入性方法。两种方法都很成功,但关于引流方法的比较却很少。本研究比较了来自单一中心的健康儿童在12年期间脓胸的临床结局。
对悉尼韦斯特米德儿童医院12年期间的病例进行回顾性分析。获得了伦理委员会的批准。
从病历中识别出72例病例,排除12例,剩余60例。平均年龄为4.7±4.3岁,男性略占优势。治疗分为单纯使用大口径引流管的手术治疗组[n = 25]和使用“猪尾导管”及胸膜内纤维蛋白溶解剂[“乌激酶”]的微创治疗组[n = 35]。就诊时平均心率和呼吸率无统计学差异。尿激酶的中位(范围)剂量为5.66剂(1 - 12剂)。使用尿激酶引流的液体更多[594毫升(25 - 4575毫升)对195毫升(10 - 1426毫升);p = 0.006],但这并未影响发热消退率或住院时间。尿激酶组42.9%和手术组68%分离出病原体,接近统计学意义[p = 0.054]。
大口径手术引流管和滴注尿激酶的“猪尾导管”引流管都能带来相似的良好治疗效果。可根据当地的专业知识和偏好推荐任何一种治疗方法。